Biblio
“Translational MRI Volumetry with NeuroQuant: Effects of Version and Normative Data on Relationships with Memory Performance in Healthy Older Adults and Patients with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1499-1510, 2017.
, “Transport of Non-Transferrin Bound Iron to the Brain: Implications for Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1109-1119, 2017.
, “Treadmill Exercise Exerts Neuroprotection and Regulates Microglial Polarization and Oxidative Stress in a Streptozotocin-Induced Rat Model of Sporadic Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1469-1484, 2017.
, “Trehalose Improves Cognition in the Transgenic Tg2576 Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 2, pp. 549-560, 2017.
, “Trends, Predictors, and Outcomes of Healthcare Resources Used in Patients Hospitalized with Alzheimer's Disease with at Least One Procedure: The Nationwide Inpatient Sample.”, J Alzheimers Dis, vol. 57, no. 3, pp. 813-824, 2017.
, “Triceps and Subscapular Skinfold in Men Aged 40-65 and Dementia Prevalence 36 Years Later.”, J Alzheimers Dis, vol. 57, no. 3, pp. 873-883, 2017.
, “Two Novel Mutations in the First Transmembrane Domain of Presenilin1 Cause Young-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1035-1041, 2017.
, “Type 1 Diabetes Mellitus and Cognitive Impairments: A Systematic Review.”, J Alzheimers Dis, vol. 57, no. 1, pp. 29-36, 2017.
, “Updating the Evidence on the Association between Serum Cholesterol and Risk of Late-Life Dementia: Review and Meta-Analysis.”, J Alzheimers Dis, vol. 56, no. 1, pp. 215-228, 2017.
, “Upregulated Expression of Heparanase and Heparanase 2 in the Brains of Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 1, pp. 185-192, 2017.
, “Urine AD7c-NTP Predicts Amyloid Deposition and Symptom of Agitation in Patients with Alzheimer's Disease and Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 60, no. 1, pp. 87-95, 2017.
, “Urine Formaldehyde Predicts Cognitive Impairment in Post-Stroke Dementia and Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1031-1038, 2017.
, “Use of Analgesics (Opioids and Nonsteroidal Anti-Inflammatory Drugs) and Dementia-Related Neuropathology in a Community-Based Autopsy Cohort.”, J Alzheimers Dis, vol. 58, no. 2, pp. 435-448, 2017.
, “The Use of Music Playlists for People with Dementia: A Critical Synthesis.”, J Alzheimers Dis, vol. 60, no. 3, pp. 1129-1142, 2017.
, “Using Drugs as Molecular Probes: A Computational Chemical Biology Approach in Neurodegenerative Diseases.”, J Alzheimers Dis, vol. 56, no. 2, pp. 677-686, 2017.
, “Utility of Molecular and Structural Brain Imaging to Predict Progression from Mild Cognitive Impairment to Dementia.”, J Alzheimers Dis, vol. 60, no. 3, pp. 939-947, 2017.
, “The Utility of the Cognitive Function Instrument (CFI) to Detect Cognitive Decline in Non-Demented Older Adults.”, J Alzheimers Dis, vol. 60, no. 2, pp. 427-437, 2017.
, “The Utilization of Robotic Pets in Dementia Care.”, J Alzheimers Dis, vol. 55, no. 2, pp. 569-574, 2017.
, “Validation by Magnetic Resonance Imaging of the Diagnostic Potential of a Heptapeptide-Functionalized Imaging Probe Targeted to Amyloid-β and Able to Cross the Blood-Brain Barrier.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1547-1565, 2017.
, “Validation of a Latent Construct for Dementia in a Population-Wide Dataset from Singapore.”, J Alzheimers Dis, vol. 55, no. 2, pp. 823-833, 2017.
, “Validation of Suspected Somatic Single Nucleotide Variations in the Brain of Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 56, no. 3, pp. 977-990, 2017.
, “Validation of the Korean Version of the Lewy Body Composite Risk Score (K-LBCRS).”, J Alzheimers Dis, vol. 55, no. 4, pp. 1395-1401, 2017.
, “Validation of the Spanish Version of the LASSI-L for Diagnosing Mild Cognitive Impairment and Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 2, pp. 733-742, 2017.
, “Validity of a Newly Developed Measure of Memory: Feasibility Study of the Virtual Environment Grocery Store.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1227-1235, 2017.
, “Varying Degrees of Temporoparietal Hypometabolism on FDG-PET Reveal Amyloid-Positive Logopenic Primary Progressive Aphasia is not a Homogeneous Clinical Entity.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1019-1029, 2017.
,